Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal "Show others and affiliations
2023 (English)In: European Journal of Neurology, ISSN 1351-5101, E-ISSN 1468-1331, Vol. 30, no 4, p. 1162-1164Article in journal, Letter (Other academic) Published
Place, publisher, year, edition, pages
John Wiley & Sons, 2023. Vol. 30, no 4, p. 1162-1164
Keywords [en]
activity, autoantibody level, biomarker, myasthenia gravis
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-502444DOI: 10.1111/ene.15690ISI: 000933229900001PubMedID: 36692238OAI: oai:DiVA.org:uu-502444DiVA, id: diva2:1759401
2023-05-252023-05-252023-05-25Bibliographically approved